![](/img/cover-not-exists.png)
P-335FOLFIRINOX versus Nab-paclitaxel plus gemcitabine in the first-line chemotherapy for patients with advanced pancreatic ductal adenocarcinoma: a multivariate analysis of prognostic factors in a national cohort (Comunica-TTD working group)
Longo Muñoz, F, Castillo Trujillo, O, Serrano Domingo, J, Martín Huertas, R, Corral de la Fuente, E, San Juan, A, Portela, J, Cano, J, Reguera Puertas, P, Rodriguez Garrote, M, Izquierdo Manuel, M, JiVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz155.334
Date:
July, 2019
File:
PDF, 98 KB
2019